Genetic Test for Opioid Addiction Risk Should Be Withdrawn, Experts Tell FDA

Source link :

A group of 31 physicians and researchers called on the FDA to reverse its decision about AvertD, a test that uses DNA to identify whether adults may have an elevated risk of developing opioid use disorder (OUD). In a letter to FDA Commissioner Robert Califf, MD, experts in genetics, addiction, psychiatry, public health, and device […]

Author : News Health

Publish date : 2024-04-04 21:29:45

Copyright for syndicated content belongs to the linked Source.